MedTrace Logo

A Study of Therapeutic Amplitude-modulated Electromagnetic Fields in Advanced Tumors

NCT00440570 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2011-06-29

No results posted yet for this study

Summary

In vitro studies suggest that low levels of amplitude-modulated electromagnetic fields may modify cell growth. We have identified specific frequencies that may block cancer cell growth. We have developed a device delivering low levels of amplitude-modulated electromagnetic fields. The device is connected to a spoon-like coupler, which is placed in the patient's mouth during treatment. We will conduct a feasibility study consisting of three daily ambulatory treatments until disease progression.

Conditions

Interventions

DEVICE

Low levels of amplitude-modulated electromagnetic fields

DEVICE

Emitter of low levels of amplitude-modulated electromagnetic fields

Sponsors & Collaborators

  • Barbault, Alexandre, M.S.

    collaborator INDIV

  • Pasche, Boris, M.D.

    lead INDIV

Principal Investigators

  • Boris C Pasche, MD, PhD · Cabinet Médical Avenue de la gare 6

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2006-09-30
Completion
2007-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00440570 on ClinicalTrials.gov